COA Available
Research In Stock Research Use Only
ARA-290
10mg · Lyophilized Powder · Purity ≥99%
ARA-290 is a synthetic 11-amino-acid peptide engineered from the tertiary structure of erythropoietin to selectively engage the innate repair receptor (IRR) — devoid of classical EPO hematopoietic activity — and used as a research tool in tissue protection, neuroprotection, and anti-inflammatory signalling research.
$69.99 CAD
Purchase Options
Subscriptions can be managed from your customer account. Prices in CAD.
Research Overview
ARA-290 is a non-hematopoietic peptide derived from the tertiary structure of erythropoietin and designed to selectively engage the innate repair receptor (IRR) — a distinct receptor complex from the classical erythropoietin receptor responsible for red blood cell production. By targeting the IRR rather than the EPO-R homodimer, ARA-290 provides a pharmacological tool for investigating cytoprotective and anti-inflammatory pathway signalling without the hematopoietic and cardiovascular effects associated with full-length erythropoietin. BME Health supplies ARA-290 as a lyophilized high-purity research peptide with Certificate of Analysis documentation. Supplied exclusively for laboratory and research use.
Preclinical studies have used ARA-290 as an IRR-targeting research tool to investigate tissue protection and anti-inflammatory signalling in models of nerve injury, metabolic stress, and ischemic injury. Phase 2 clinical investigations have examined ARA-290 in neuropathy and metabolic disease research contexts, providing translational data on IRR biology and tolerability — though no regulatory approval has been granted. Its selectivity for the IRR over the classical EPO-R makes ARA-290 a valuable discriminator in erythropoietin receptor pharmacology research. All outcomes referenced do not constitute evidence of clinical efficacy or safety in humans.
Specifications
| Compound | ARA-290 |
| Format | Lyophilized Powder |
| Size | 10mg |
| Purity (HPLC) | ≥99% |
| Item # | BME-ARA290-A |
| Storage | −20°C, dry, dark |
| Price (CAD) | $69.99 |
COA / Testing
Batch documentation and third-party testing information are available for batch BME-ARA290-A. COA previews appear only when documentation exists for the active batch.
Storage & Handling
Store lyophilized ARA-290 at −20°C in a dry, light-protected environment. Reconstituted solutions should be prepared in sterile research-grade buffer and used promptly; repeated freeze-thaw cycles degrade peptide integrity and should be avoided. Vials should be checked for physical integrity upon receipt before commencing research preparations.
Shipping & Returns
Orders are processed on business days. Packaging is selected to maintain compound integrity in transit. Shipping timelines and return conditions are outlined in full in the Shipping & Returns policy — review before checkout if you have specific requirements. For orders with time-sensitive research schedules, contact support before placing your order.
Research Use Disclaimer
This product is supplied strictly for in-vitro and laboratory research use. It is not a drug, food supplement, or cosmetic and is not approved for human or veterinary clinical applications, diagnostics, or therapeutic use. Researchers are responsible for compliance with all applicable institutional and regulatory requirements in their jurisdiction.
Preparation Reference Guide
Research Solution Reference Calculator
Pre-filled with 10mg. Enter your solvent volume and target amount to see concentration and units on a U-100 syringe scale.
Concentration—
Volume to draw—
Syringe units (U-100)—
Per insulin unit—
For research-use calculations only. Always verify measurements independently — not medical guidance.
Questions before you order?
Browse the FAQ for documentation, storage, and sourcing answers, or contact our support team directly. We aim to respond to all research procurement inquiries within one business day.
Related
